{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:41:42Z","timestamp":1793835702330,"version":"4.6.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Natural Science Foundation of China","award":["2022QNA054"],"award-info":[{"award-number":["2022QNA054"]}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82074542"],"award-info":[{"award-number":["82074542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Funds for the innovation of Science and Technology, Fujian province","award":["2020Y94020265"],"award-info":[{"award-number":["2020Y94020265"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023ZQNZD01010013"],"award-info":[{"award-number":["2023ZQNZD01010013"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"DOI":"10.1186\/s12978-025-02016-y","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:16:53Z","timestamp":1747718213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Changes in the global burden of polycystic ovary syndrome from 1990 to 2021"],"prefix":"10.1186","volume":"22","author":[{"given":"Tong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"3","key":"2016_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cen.13795","volume":"89","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol. 2018;89(3):251\u201368.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2016_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jama.2021.23769","volume":"327","author":"HG Huddleston","year":"2022","unstructured":"Huddleston HG, Dokras A. Diagnosis and treatment of polycystic ovary syndrome. Jama J Am Med Assoc. 2022;327(3):274\u20135.","journal-title":"Jama J Am Med Assoc"},{"issue":"9","key":"2016_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2016_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/jama.2021.19776","volume":"327","author":"K Walter","year":"2022","unstructured":"Walter K. What is polycystic ovary syndrome? Jama J Am Med Assoc. 2022;327(3):294.","journal-title":"Jama J Am Med Assoc"},{"key":"2016_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110593","volume":"198","author":"D Appiah","year":"2023","unstructured":"Appiah D, Hedderson MM, Kim C, Sidney S, Sternfeld B, Quesenberry CP, et al. The prospective association of hyperandrogenism, oligomenorrhea and polycystic ovary syndrome with incident gestational diabetes: the coronary artery risk development in young adults women\u2019s study. Diabetes Res Clin Pract. 2023;198: 110593.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2016_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ajog.2021.07.032","volume":"226","author":"M Kazemi","year":"2022","unstructured":"Kazemi M, Kim JY, Wan C, Xiong JD, Parry SA, Azziz R, et al. Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(2):187-204.e15.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2016_CR7","volume":"94","author":"VV Khalenko","year":"2023","unstructured":"Khalenko VV, Guiglia RA, Alioto M. Are women with PCOS more at risk for endometrial cancer? What approach for such patients? Acta Bio Med Atenei Parmensis. 2023;94(2): e2023081.","journal-title":"Acta Bio Med Atenei Parmensis"},{"issue":"6","key":"2016_CR8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/humupd\/dmac023","volume":"28","author":"M Kazemi","year":"2022","unstructured":"Kazemi M, Kim JY, Wan C, Xiong JD, Michalak J, Xavier IB, et al. Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39 471 women. Hum Reprod Update. 2022;28(6):910\u201355.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2016_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.8685","volume":"6","author":"N Zaks","year":"2023","unstructured":"Zaks N, Batuure A, Lin E, Rommel AS, Reichenberg A, Grice D, et al. Association between mental health and reproductive system disorders in women: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(4): e238685.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2016_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41574-024-00963-3","volume":"20","author":"RE Campbell","year":"2024","unstructured":"Campbell RE. Beyond the ovary: rewiring our perspective on polycystic ovary syndrome. Nat Rev Endocrinol. 2024;20(5):257.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2016_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/healthcare11040562","volume":"11","author":"Y Gao","year":"2023","unstructured":"Gao Y, Liu H, Qiao L, Liang J, Yao H, Lin X, et al. Study of burden in polycystic ovary syndrome at global, regional, and national levels from 1990 to 2019. Healthcare (Basel). 2023;11(4):562.","journal-title":"Healthcare (Basel)"},{"issue":"4","key":"2016_CR12","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","volume":"36","author":"J Liu","year":"2021","unstructured":"Liu J, Wu Q, Hao Y, Jiao M, Wang X, Jiang S, et al. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: global burden of disease study 2017. Hum Reprod. 2021;36(4):1108\u201319.","journal-title":"Hum Reprod"},{"issue":"2","key":"2016_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5114\/aoms.2019.87112","volume":"17","author":"T Miazgowski","year":"2021","unstructured":"Miazgowski T, Martopullo I, Widecka J, Miazgowski B, Brodowska A. National and regional trends in the prevalence of polycystic ovary syndrome since 1990 within Europe: the modeled estimates from the Global Burden of Disease Study 2016. Arch Med Sci. 2021;17(2):343\u201351.","journal-title":"Arch Med Sci"},{"issue":"8","key":"2016_CR14","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/humrep\/deac091","volume":"37","author":"S Safiri","year":"2022","unstructured":"Safiri S, Noori M, Nejadghaderi SA, Karamzad N, Carson-Chahhoud K, Sullman MJM, et al. Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990\u20132019. Hum Reprod. 2022;37(8):1919\u201331.","journal-title":"Hum Reprod"},{"issue":"7","key":"2016_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306991","volume":"19","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhu Y, Wang J, Hu H, Jin Y, Mao X, et al. Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: a systematic analysis from the Global Burden of Disease Study 2019. PLoS ONE. 2024;19(7): e0306991.","journal-title":"PLoS ONE"},{"issue":"10440","key":"2016_CR16","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"GF Collaborators","year":"2024","unstructured":"Collaborators GF. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2204\u201356.","journal-title":"Lancet"},{"key":"2016_CR17","doi-asserted-by":"crossref","unstructured":"Group REA-SPcw. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod. 2004;19(1):41\u20137.","DOI":"10.1093\/humrep\/deh098"},{"issue":"4","key":"2016_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/humrep\/dex029","volume":"32","author":"T Copp","year":"2017","unstructured":"Copp T, McCaffery K, Azizi L, Doust J, Mol BWJ, Jansen J. Influence of the disease label \u2018polycystic ovary syndrome\u2019 on intention to have an ultrasound and psychosocial outcomes: a randomised online study in young women. Hum Reprod. 2017;32(4):876\u201384.","journal-title":"Hum Reprod"},{"issue":"9","key":"2016_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41574-021-00517-x","volume":"17","author":"E Stener-Victorin","year":"2021","unstructured":"Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome\u2014challenges and opportunities for treatment. Nat Rev Endocrinol. 2021;17(9):521\u201333.","journal-title":"Nat Rev Endocrinol"},{"key":"2016_CR20","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1038\/ncomms9464","volume":"6","author":"FR Day","year":"2015","unstructured":"Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;6:8464.","journal-title":"Nat Commun"},{"issue":"8","key":"2016_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.molmed.2021.05.005","volume":"27","author":"E Stener-Victorin","year":"2021","unstructured":"Stener-Victorin E, Deng Q. Transmission of polycystic ovary syndrome via epigenetic inheritance. Trends Mol Med. 2021;27(8):723\u20134.","journal-title":"Trends Mol Med"},{"issue":"5","key":"2016_CR22","doi-asserted-by":"publisher","first-page":"57001","DOI":"10.1289\/EHP11814","volume":"131","author":"W Zhan","year":"2023","unstructured":"Zhan W, Qiu W, Ao Y, Zhou W, Sun Y, Zhao H, et al. Environmental exposure to emerging alternatives of Per- and Polyfluoroalkyl substances and polycystic ovarian syndrome in women diagnosed with infertility: a mixture analysis. Environ Health Perspect. 2023;131(5):57001.","journal-title":"Environ Health Perspect"},{"key":"2016_CR23","doi-asserted-by":"publisher","first-page":"1335028","DOI":"10.3389\/fcell.2024.1335028","volume":"12","author":"S Zhang","year":"2024","unstructured":"Zhang S, Gao F, Fu M, Zhang Q, Guan J, Shen H. Reproductive toxicology of environmental endocrine-disrupting chemicals in women: a cohort study protocol. Front Cell Dev Biol. 2024;12:1335028.","journal-title":"Front Cell Dev Biol"},{"key":"2016_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.157780","volume":"849","author":"C Liang","year":"2022","unstructured":"Liang C, Zhang Z, Cao Y, Wang J, Shen L, Jiang T, et al. Exposure to multiple toxic metals and polycystic ovary syndrome risk: endocrine disrupting effect from As, Pb and Ba. Sci Total Environ. 2022;849: 157780.","journal-title":"Sci Total Environ"},{"issue":"2","key":"2016_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/clinem\/dgab613","volume":"107","author":"C Riestenberg","year":"2022","unstructured":"Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health care-related economic burden of polycystic ovary syndrome in the united states: pregnancy-related and long-term health consequences. J Clin Endocr Metab. 2022;107(2):575\u201385.","journal-title":"J Clin Endocr Metab"},{"issue":"12","key":"2016_CR26","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841\u201355.","journal-title":"Hum Reprod"},{"issue":"3","key":"2016_CR27","first-page":"330","volume":"23","author":"M Chen","year":"2025","unstructured":"Chen M, Nguyen W, Haq Z, Guo W, Briley J. Prevalence of female hirsutism and PCOS in the United States: a cross-sectional study. J Dtsch Dermatol Ges. 2025;23(3):330\u20138.","journal-title":"J Dtsch Dermatol Ges"},{"key":"2016_CR28","first-page":"1","volume":"00","author":"AT Wolf","year":"2024","unstructured":"Wolf AT, Wang Z, Onnela JP, Baird DD, Jukic AMZ, Curry CL, et al. Signs of potential androgen excess across the lifespan in a US-based digital cohort study. J Clin Endocr Metab. 2024;00:1\u201313.","journal-title":"J Clin Endocr Metab"},{"key":"2016_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejogrb.2022.10.020","volume":"279","author":"F Chiaffarino","year":"2022","unstructured":"Chiaffarino F, Cipriani S, Dalmartello M, Ricci E, Esposito G, Fedele F, et al. Prevalence of polycystic ovary syndrome in European countries and USA: a systematic review and meta-analysis. Eur J Obstet Gyn R B. 2022;279:159\u201370.","journal-title":"Eur J Obstet Gyn R B"},{"key":"2016_CR30","first-page":"1","volume":"00","author":"M Amiri","year":"2025","unstructured":"Amiri M, Hatoum S, Buyalos RP, Sheidaei A, Azziz R. The influence of study quality, age, and geographic factors on pcos prevalence\u2014a systematic review and meta-analysis. J Clin Endocr Metab. 2025;00:1\u201322.","journal-title":"J Clin Endocr Metab"},{"issue":"1","key":"2016_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/humupd\/dmad027","volume":"30","author":"J Pea","year":"2024","unstructured":"Pea J, Bryan J, Wan C, Oldfield AL, Ganga K, Carter FE, et al. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis. Hum Reprod Update. 2024;30(1):109\u201330.","journal-title":"Hum Reprod Update"},{"issue":"8","key":"2016_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/humrep\/deae124","volume":"39","author":"D Glintborg","year":"2024","unstructured":"Glintborg D, Ollila MM, M\u00f8ller JK, Pesonen P, Persson S, Elenis E, et al. Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden. Hum Reprod. 2024;39(8):1823\u201334.","journal-title":"Hum Reprod"},{"issue":"2","key":"2016_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(19)30345-6","volume":"8","author":"EP Thong","year":"2020","unstructured":"Thong EP, Codner E, Laven JSE, Teede H. Diabetes: a metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 2020;8(2):134\u201349.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2016_CR34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/cen.14063","volume":"91","author":"E Carmina","year":"2019","unstructured":"Carmina E, Nasrallah MP, Guastella E, Lobo RA. Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily. Clin Endocrinol. 2019;91(4):553\u201360.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2016_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13048-023-01329-5","volume":"17","author":"S Syed","year":"2024","unstructured":"Syed S, Gragnoli C. The glucocorticoid receptor gene (NR3C1) is linked to and associated with polycystic ovarian syndrome in Italian families. J Ovarian Res. 2024;17(1):13.","journal-title":"J Ovarian Res"},{"issue":"5","key":"2016_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1515\/jpem-2015-0423","volume":"29","author":"A Ciresi","year":"2016","unstructured":"Ciresi A, Amato MC, Bianco J, Giordano C. Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency. J Pediatr Endocrinol Metab. 2016;29(5):571\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"2016_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.numecd.2018.02.009","volume":"28","author":"E Bonora","year":"2018","unstructured":"Bonora E, Monami M, Bruno G, Zoppini G, Mannucci E. Attending Diabetes Clinics is associated with a lower all-cause mortality. A meta-analysis of observational studies performed in Italy. Nutr Metabol Cardiovasc Dis. 2018;28(5):431\u20135.","journal-title":"Nutr Metabol Cardiovasc Dis."},{"issue":"11","key":"2016_CR38","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.3390\/nu13113925","volume":"13","author":"L Barrea","year":"2021","unstructured":"Barrea L, Muscogiuri G, Pugliese G, de Alteriis G, Colao A, Savastano S. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition. Nutrients. 2021;13(11):3925.","journal-title":"Nutrients"},{"issue":"6","key":"2016_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000519302","volume":"77","author":"X Che","year":"2021","unstructured":"Che X, Chen Z, Liu M, Mo Z. Dietary interventions: a promising treatment for polycystic ovary syndrome. Ann Nutr Metab. 2021;77(6):313\u201323.","journal-title":"Ann Nutr Metab"},{"key":"2016_CR40","doi-asserted-by":"crossref","unstructured":"Yu O, Christ JP, Schulze-Rath R, Covey J, Kelley A, Grafton J, et al. Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019. Am J Obstet Gynecol. 2023;229(1):39.e1-.e12.","DOI":"10.1016\/j.ajog.2023.04.010"},{"issue":"4","key":"2016_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/MOP.0000000000001255","volume":"35","author":"SA DiVall","year":"2023","unstructured":"DiVall SA. Practical considerations for diagnosis and treatment of polycystic ovary syndrome in adolescence - distilling guidelines into clinical practice. Curr Opin Pediatr. 2023;35(4):494\u20139.","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"2016_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-020-01516-x","volume":"18","author":"AS Pe\u00f1a","year":"2020","unstructured":"Pe\u00f1a AS, Witchel SF, Hoeger KM, Oberfield SE, Vogiatzi MG, Misso M, et al. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18(1):72.","journal-title":"BMC Med"},{"issue":"1","key":"2016_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12916-020-01861-x","volume":"18","author":"CT Tay","year":"2020","unstructured":"Tay CT, Hart RJ, Hickey M, Moran LJ, Earnest A, Doherty DA, et al. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020;18(1):389.","journal-title":"BMC Med"},{"key":"2016_CR44","doi-asserted-by":"crossref","unstructured":"Gupta J, Antal Z, Censani M. Prevalence of impaired glucose tolerance in adolescent patients with polycystic ovary syndrome in an urban health care center. Diabetes. 2018;67(Supple 1):722.","DOI":"10.2337\/db18-722-P"},{"issue":"5","key":"2016_CR45","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-064894","volume":"153","author":"RC Whooten","year":"2024","unstructured":"Whooten RC, Rifas-Shiman SL, Perng W, Chavarro JE, Taveras E, Oken E, et al. Associations of childhood adiposity and Cardiometabolic biomarkers with adolescent PCOS. Pediatrics. 2024;153(5): e2023064894.","journal-title":"Pediatrics"},{"issue":"1","key":"2016_CR46","doi-asserted-by":"publisher","first-page":"22934","DOI":"10.1038\/s41598-024-74347-y","volume":"14","author":"H Bai","year":"2024","unstructured":"Bai H, Zhang S, Huang J, Diao K, Li C, Wang M. Unraveling the pathogenic interplay between SARS-CoV-2 and polycystic ovary syndrome using bioinformatics and experimental validation. Sci Rep. 2024;14(1):22934.","journal-title":"Sci Rep"},{"key":"2016_CR47","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.3390\/ijms22094472","volume":"22","author":"AM Huffman","year":"2021","unstructured":"Huffman AM, Rezq S, Basnet J, Yanes Cardozo LL, Romero DG. SARS-CoV-2 viral entry proteins in hyperandrogenemic female mice: implications for women with PCOS and COVID-19. Int J Mol Sci. 2021;22:4472.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2016_CR48","doi-asserted-by":"publisher","first-page":"9746","DOI":"10.3390\/ijms22189746","volume":"22","author":"S Rezq","year":"2021","unstructured":"Rezq S, Huffman AM, Basnet J, Yanes Cardozo LL, Romero DG. Cardiac and Renal SARS-CoV-2 viral entry protein regulation by androgens and diet: implications for polycystic ovary syndrome and COVID-19. Int J Mol Sci. 2021;22(18):9746.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2016_CR49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.fertnstert.2023.01.025","volume":"119","author":"S Alur-Gupta","year":"2023","unstructured":"Alur-Gupta S, Boland MR, Dokras A. Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome. Fertil Steril. 2023;119(5):847\u201357.","journal-title":"Fertil Steril"},{"issue":"2","key":"2016_CR50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11154-022-09715-y","volume":"23","author":"SF de Medeiros","year":"2022","unstructured":"de Medeiros SF, Yamamoto MMW, de Medeiros MAS, Yamamoto A, Barbosa BB. Polycystic ovary syndrome and risks for COVID-19 infection: a comprehensive review\u202f: PCOS and COVID-19 relationship. Rev Endocr Metab Dis. 2022;23(2):251\u201364.","journal-title":"Rev Endocr Metab Dis"},{"key":"2016_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105770","volume":"205","author":"G Morgante","year":"2021","unstructured":"Morgante G, Tro\u00eca L, De Leo V. Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women? J Steroid Biochem. 2021;205: 105770.","journal-title":"J Steroid Biochem"},{"issue":"5","key":"2016_CR52","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1530\/EJE-20-1163","volume":"184","author":"A Subramanian","year":"2021","unstructured":"Subramanian A, Anand A, Adderley NJ, Okoth K, Toulis KA, Gokhale K, et al. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur J Endocrinol. 2021;184(5):637\u201345.","journal-title":"Eur J Endocrinol"},{"key":"2016_CR53","doi-asserted-by":"publisher","first-page":"1229900","DOI":"10.3389\/fendo.2023.1229900","volume":"14","author":"Y Si","year":"2023","unstructured":"Si Y, Fei Y, Ma H, Xu Y, Ning L, Li X, et al. The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data. Front Endocrinol (Lausanne). 2023;14:1229900.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2016_CR54","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12916-020-01697-5","volume":"18","author":"I Kyrou","year":"2020","unstructured":"Kyrou I, Karteris E, Robbins T, Chatha K, Drenos F, Randeva HS. Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 2020;18(1):220.","journal-title":"BMC Med"},{"key":"2016_CR55","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S504439","volume":"17","author":"BC Sydora","year":"2025","unstructured":"Sydora BC, Wilke MS, Ghosh M, Vine DF. The impact of the COVID-19 pandemic on health and health care experience in those with polycystic ovary syndrome. Int J Womens Health. 2025;17:287\u201398.","journal-title":"Int J Womens Health"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-025-02016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-025-02016-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-025-02016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:52:35Z","timestamp":1747720355000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-025-02016-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2016"],"URL":"https:\/\/doi.org\/10.1186\/s12978-025-02016-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5823228\/v1","asserted-by":"object"}]},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}